Facebook Twitter LinkedIn Email

Point-of-Care Reference Tools

As more pharmaceutical COVID-19 treatment and prevention options become authorized or approved, health care providers need easy access to concise information about guidelines, dosing, safety and other key clinical and administrative considerations. Our collection of quick-reference tools provides downloadable and printable information on outpatient treatment options, including an outpatient treatment roadmap as well as point-of-care references for nirmatrelvir/ritonavir (Paxlovid™), molnupiravir, remdesivir and tixagevimab/cilgavimab (Evusheld™).

 

COVID-19 Outpatient Treatment Guidelines Roadmap

Nirmatrelvir/Ritonavir (Paxlovid™) Point-of-Care Reference

Remdesivir Point-of-Care Reference

Molnupiravir Point-of-Care Reference

Tixagevimab & Cilgavimab (Evusheld™) Point-of-Care Reference

For more in-depth scientific information, including key literature summaries, please refer to our Real-Time Learning Network therapeutics pages.

Sign up for IDSA's Newsletter
Stay informed with daily resources, media and news.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.